This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of compounds targeting neurological and psychiatric disorders. Its structure, featuring a piperazine moiety, makes it valuable in designing molecules that interact with neurotransmitter systems, such as dopamine and serotonin receptors. It is also employed in research settings to explore potential therapeutic agents for conditions like depression, anxiety, and schizophrenia. Additionally, its role in medicinal chemistry extends to the creation of analogs and derivatives for optimizing drug efficacy and selectivity.